N
Norihiro Kokudo
Researcher at University of Tokyo
Publications - 918
Citations - 39158
Norihiro Kokudo is an academic researcher from University of Tokyo. The author has contributed to research in topics: Liver transplantation & Hepatectomy. The author has an hindex of 86, co-authored 849 publications receiving 32035 citations. Previous affiliations of Norihiro Kokudo include Juntendo University & Meikai University.
Papers
More filters
Journal ArticleDOI
Recent Progress in the Treatment and Diagnosis of Hepatocellular Carcinoma
TL;DR: This meeting is planning to have symposiums on the perioperative management, surgical resection, laparoscopic hepatectomy, and treatments for advanced HCC, surgery versus RFA, progress of imaging studies, liver transplantation, biomarkers, chemotherapy, guidelines for management, and surveillance of HCC.
Journal ArticleDOI
Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial.
Osamu Aramaki,Tadatoshi Takayama,Masamichi Moriguchi,Hidemori Sakamoto,Hiraku Yodono,Norihiro Kokudo,Naoki Yamanaka,Seiji Kawasaki,Yo Sasaki,Keiichi Kubota,Eigo Otsuji,Shinji Tanaka,Yutaka Matsuyama,Masashi Fujii +13 more
TL;DR: In this paper, the authors compared the efficacy of TACE with cisplatin versus with epirubicin in patients with unresectable hepatocellular carcinoma (HCC).
Journal ArticleDOI
Elastography for hepato-biliary-pancreatic surgery.
Yosuke Inoue,Norihiro Kokudo +1 more
TL;DR: The quantification of stiffness also enables non-invasive estimates of liver fibrosis, the risk of postoperative liver insufficiency and therisk of recurrence of viral hepatitis after transplantation.
Journal ArticleDOI
Treatment with ribavirin for chronic hepatitis E following living donor liver transplantation: A case report
Tomohiro Tanaka,Nobuhisa Akamatsu,Yoshihiro Sakamoto,Yuki Inagaki,Yukio Oshiro,Nobuhiro Ohkohchi,Hiroaki Okamoto,Norihiro Kokudo +7 more
TL;DR: A first case of established chronic hepatitis E after LDLT that was successfully and safely treated with a 20-week course of ribavirin is described.
Journal ArticleDOI
Two cases with hepatic amyloidosis suspected of having primary sclerosing cholangitis.
Kenji Hirano,Masako Ikemura,Suguru Mizuno,Minoru Tada,Hiroyuki Isayama,Takeo Watanabe,Tomotaka Saito,Shuhei Kawahata,Rie Uchino,Tsuyoshi Hamada,Koji Miyabayashi,Takashi Sasaki,Hirofumi Kogure,Natsuyo Yamamoto,Naoki Sasahira,Kazuhiko Koike,Masashi Fukayama,Yasuhiko Sugawara,Norihiro Kokudo +18 more
TL;DR: It is important to consider hepatic amyloidosis as a differential diagnosis of primary sclerosing cholangitis (PSC), and the presence of atypical extrahepatic lesions may be useful clues for confirming the diagnosis.